» Articles » PMID: 38785980

Failure of Autophagy in Pompe Disease

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 May 24
PMID 38785980
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is an evolutionarily conserved lysosome-dependent degradation of cytoplasmic constituents. The system operates as a critical cellular pro-survival mechanism in response to nutrient deprivation and a variety of stress conditions. On top of that, autophagy is involved in maintaining cellular homeostasis through selective elimination of worn-out or damaged proteins and organelles. The autophagic pathway is largely responsible for the delivery of cytosolic glycogen to the lysosome where it is degraded to glucose via acid α-glucosidase. Although the physiological role of lysosomal glycogenolysis is not fully understood, its significance is highlighted by the manifestations of Pompe disease, which is caused by a deficiency of this lysosomal enzyme. Pompe disease is a severe lysosomal glycogen storage disorder that affects skeletal and cardiac muscles most. In this review, we discuss the basics of autophagy and describe its involvement in the pathogenesis of muscle damage in Pompe disease. Finally, we outline how autophagic pathology in the diseased muscles can be used as a tool to fast track the efficacy of therapeutic interventions.

Citing Articles

Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease.

Moschetti M, Venezia M, Giacomarra M, Marsana E, Zizzo C, Duro G Int J Mol Sci. 2025; 26(2).

PMID: 39859472 PMC: 11766448. DOI: 10.3390/ijms26020757.

References
1.
Chan J, Desai A, Kazi Z, Corey K, Austin S, Hobson-Webb L . The emerging phenotype of late-onset Pompe disease: A systematic literature review. Mol Genet Metab. 2017; 120(3):163-172. DOI: 10.1016/j.ymgme.2016.12.004. View

2.
Sanchez-Porras V, Guevara-Morales J, Echeverri-Pena O . From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease. Int J Mol Sci. 2023; 24(15). PMC: 10419125. DOI: 10.3390/ijms241512481. View

3.
Gomez-Cebrian N, Gras-Colomer E, Poveda Andres J, Pineda-Lucena A, Puchades-Carrasco L . Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes. Biology (Basel). 2023; 12(9). PMC: 10525434. DOI: 10.3390/biology12091159. View

4.
Vaghela R, Arkudas A, Horch R, Hessenauer M . Actually Seeing What Is Going on - Intravital Microscopy in Tissue Engineering. Front Bioeng Biotechnol. 2021; 9:627462. PMC: 7925911. DOI: 10.3389/fbioe.2021.627462. View

5.
Raben N, Fukuda T, Gilbert A, de Jong D, Thurberg B, Mattaliano R . Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol Ther. 2004; 11(1):48-56. DOI: 10.1016/j.ymthe.2004.09.017. View